Hydrogel degradation promotes angiogenic and regenerative potential of cell spheroids for wound healing.

Degradation Endothelial cell Mesenchymal stromal cell Spheroids poly(ethylene) glycol

Journal

Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 04 06 2023
revised: 27 07 2023
accepted: 09 08 2023
medline: 28 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: epublish

Résumé

Chronic nonhealing wounds are debilitating and diminish one's quality of life, necessitating the development of improved strategies for effective treatment. Biomaterial- and cell-based therapies offer an alternative treatment compared to conventional wound care for regenerating damaged tissues. Cell-based approaches frequently utilize endothelial cells (ECs) to promote vascularization and mesenchymal stromal cells (MSCs) for their potent secretome that promotes host cell recruitment. Spheroids have improved therapeutic potential over monodisperse cells, while degradable scaffolds can influence cellular processes conducive to long-term tissue regeneration. However, the role of biomaterial degradation on the therapeutic potential of heterotypic EC-MSC spheroids for wound healing is largely unknown. We formed poly(ethylene) glycol (PEG) hydrogels with varying ratios of matrix metalloproteinase (MMP)-degradable and non-degradable crosslinkers to develop three distinct constructs - fully degradable, partially degradable, and non-degradable - and interrogate the influence of degradation rate on engineered cell carriers for wound healing. We found that the vulnerability to degradation was critical for cellular proliferation, while inhibition of degradation impaired spheroid metabolic activity. Higher concentrations of degradable crosslinker promoted robust cell spreading, outgrowth, and secretion of proangiogenic cytokines (

Identifiants

pubmed: 37636986
doi: 10.1016/j.mtbio.2023.100769
pii: S2590-0064(23)00229-6
pmc: PMC10450977
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100769

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Kent Leach reports financial support was provided by 10.13039/100000002National Institutes of Health. Kent Leach reports a relationship with Journal of Biomedical Materials Research Part A that includes: board membership.

Références

Cell Mol Bioeng. 2018 Aug;11(4):267-278
pubmed: 30416603
Mol Ther. 2018 Feb 7;26(2):606-617
pubmed: 29066165
Arthritis Res Ther. 2013 Apr 27;15(2):R57
pubmed: 23621950
Chem Soc Rev. 2013 Sep 7;42(17):7335-72
pubmed: 23609001
J Tissue Eng Regen Med. 2019 Aug;13(8):1430-1437
pubmed: 31070860
Stem Cells. 2004;22(3):405-14
pubmed: 15153617
Mol Biol Cell. 2012 Mar;23(6):1068-79
pubmed: 22262460
J Cell Biol. 2016 Jan 4;212(1):113-24
pubmed: 26711502
Methods Mol Biol. 2018;1758:139-149
pubmed: 29679328
Adv Mater. 2012 Jan 3;24(1):64-70, 2
pubmed: 22174081
Stem Cell Res Ther. 2020 May 27;11(1):205
pubmed: 32460846
NPJ Regen Med. 2022 Dec 9;7(1):70
pubmed: 36494368
Adv Wound Care (New Rochelle). 2021 May;10(5):281-292
pubmed: 33733885
Stem Cells Transl Med. 2016 Jun;5(6):773-81
pubmed: 27057004
Adv Mater. 2016 Mar 2;28(9):1809-17
pubmed: 26695434
Adv Wound Care (New Rochelle). 2020 Mar 1;9(3):127-143
pubmed: 31993254
Nat Rev Mater. 2016 Dec;1(12):
pubmed: 29657852
Biomaterials. 2020 Dec;263:120377
pubmed: 32947094
Biomaterials. 2023 Jul 25;301:122256
pubmed: 37517209
Biol Reprod. 2001 Dec;65(6):1726-31
pubmed: 11717134
Stem Cell Rev Rep. 2020 Oct;16(5):853-875
pubmed: 32681232
Biomaterials. 2008 Jun;29(18):2757-66
pubmed: 18396331
Microvasc Res. 1993 Jul;46(1):77-88
pubmed: 8412854
Biomaterials. 2010 May;31(14):3840-7
pubmed: 20185173
Biomaterials. 2018 Oct;181:189-198
pubmed: 30086448
Stem Cells Transl Med. 2018 Sep;7(9):651-663
pubmed: 30070053
Biomaterials. 2014 Aug;35(26):7295-307
pubmed: 24909102
Ann Biomed Eng. 2014 Feb;42(2):312-22
pubmed: 23881112
J Mol Med (Berl). 2020 Mar;98(3):425-435
pubmed: 32020237
Bioact Mater. 2021 Apr 30;6(12):4342-4359
pubmed: 33997511
Curr Protoc Stem Cell Biol. 2008 Jul;Chapter 2:Unit 2C.1
pubmed: 18770637
Biomaterials. 2021 Feb;269:120356
pubmed: 33189358
ACS Biomater Sci Eng. 2016 Nov 14;2(11):1914-1925
pubmed: 29503863
PLoS One. 2008 Apr 02;3(4):e1886
pubmed: 18382669
Tissue Eng Part A. 2011 Dec;17(23-24):2931-42
pubmed: 21882895
Tissue Eng Part A. 2009 Mar;15(3):559-67
pubmed: 18724832
Biomaterials. 2011 Apr;32(11):2734-47
pubmed: 21262528
Adv Wound Care (New Rochelle). 2015 Apr 1;4(4):225-234
pubmed: 25945285
Stem Cells Transl Med. 2015 Jul;4(7):852-61
pubmed: 25947337
Biomaterials. 2013 Jun;34(19):4602-11
pubmed: 23541111
J Am Podiatr Med Assoc. 2002 Jan;92(1):12-8
pubmed: 11796794
Clin Dermatol. 2007 Jan-Feb;25(1):19-25
pubmed: 17276197
Ann Biomed Eng. 2023 Jul;51(7):1558-1573
pubmed: 36809393
Biomaterials. 2019 Oct;217:119294
pubmed: 31276949
J Dent Res. 2010 Mar;89(3):219-29
pubmed: 20139336
Nat Protoc. 2018 Sep;13(9):2102-2119
pubmed: 30190557
Nat Commun. 2021 May 28;12(1):3227
pubmed: 34050161
Ann N Y Acad Sci. 2018 Jan;1411(1):153-165
pubmed: 29377202
Biomaterials. 2021 May;272:120769
pubmed: 33798961
Stem Cell Res Ther. 2021 Jan 7;12(1):11
pubmed: 33413584
Nat Commun. 2020 Jan 8;11(1):114
pubmed: 31913286
Syst Rev. 2016 Sep 08;5(1):152
pubmed: 27609108
Biomaterials. 2017 Sep;140:103-114
pubmed: 28644976
Acta Biomater. 2019 Apr 1;88:280-292
pubmed: 30721783
Biomaterials. 2013 Mar;34(10):2501-15
pubmed: 23317813
Acta Biomater. 2017 Mar 1;50:437-449
pubmed: 28039063

Auteurs

Victoria L Thai (VL)

Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA, 95817, USA.
Department of Biomedical Engineering, UC Davis, Davis, CA, 95616, USA.

David H Ramos-Rodriguez (DH)

Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA, 95817, USA.

Meron Mesfin (M)

Department of Biomedical Engineering, UC Davis, Davis, CA, 95616, USA.

J Kent Leach (JK)

Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA, 95817, USA.
Department of Biomedical Engineering, UC Davis, Davis, CA, 95616, USA.

Classifications MeSH